TrialEpilepsia open2024

Efficacy and Safety of adjunctive Perampanel in a prospective, real-world, Phase IV study in Indian patients aged ≥12 years for Treatment of focal-onset Epilepsy: Study 508.

Sangeeta Ravat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.